News
MATAWAN, N.J., Nov 15, 2007 (BUSINESS WIRE) -- iVoice, Inc., (OTC Bulletin Board: IVOI), today announced that it has completed the spin-off of its wholly-owned subsidiary Thomas Pharmaceuticals Ltd. iVoice will distribute through a special dividend the Class A Common Stock shares of the subsidiary to its shareholders, and thereafter, the entity will operate as independent public company.
Each iVoice shareholder of record on November 14 2007 will receive one (1) share of Thomas Pharmaceuticals for every one (1) share of iVoice, Inc. that they own as of the record date. In order to receive shares in Thomas Pharmaceuticals, you must have owned shares of iVoice, Inc. on the record date of, November 14 2007. iVoice shareholders can expect to receive the Thomas Pharmaceuticals Ltd. shares in the next few weeks.
Thomas Pharmaceuticals Ltd. will file the appropriate paperwork with the NASD to begin trading on the NASD Over the Counter Bulletin Board. The companies expect that the shares will commence trading sometime in the next several months.
Registration statements relating to the securities of Thomas Pharmaceuticals Ltd. have been filed with and declared effective by the Securities and Exchange Commission. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor there any sale of these securities in any state in which such offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
